University of Melbourne multicentre study — MediPaws Sydney site

University / teaching hospital

1 current cancer treatment or research opportunity

About the University of Melbourne haemangiosarcoma study

A University of Melbourne-led multicentre study tests an autologous tumour vaccine alongside doxorubicin chemotherapy after surgery for canine splenic haemangiosarcoma. MediPaws in Leichhardt, Sydney, is a verified participating hospital actively enrolling eligible dogs.

MediPaws study and eligibility →

Who the current listings are forDogs
Cancer types currently listedHemangiosarcoma
Where visits take place233 Catherine Street, Leichhardt NSW 2040, Australia

Current options at University of Melbourne multicentre study — MediPaws Sydney site

Open an option to see who may qualify, locations, costs or coverage, contact details and the official source.

Autologous tumour vaccine with doxorubicin after surgery for canine splenic hemangiosarcoma

University of Melbourne multicentre study — MediPaws Sydney site · Australia

Recruiting at MediPaws Sydney — participating site confirms active enrolment

What is being offered: Autologous tumour vaccine prepared from the resected splenic tumour, added to standard doxorubicin chemotherapy

Who may qualify: Confirmed cancer diagnosis required; No metastasis; Splenic primary; Post splenectomy; Planned doxorubicin

Costs / coverage: 🟡 The autologous tumour vaccine is free. Owners pay for standard veterinary care, including doxorubicin chemotherapy and associated costs.

Contact: MediPaws oncology, Dr Sonya Yu: 1800 678 387; contact via the MediPaws clinical research page

Location

  • MediPaws, 233 Catherine Street, Leichhardt NSW 2040, Australia, Sydney, New South Wales

Official study / enrollment information →

Before you contact the center

A listing here does not mean every pet will qualify. Enrollment can change, and the study team makes the final decision after reviewing your pet’s diagnosis, records and previous treatment.

Have the pathology report, recent imaging and treatment history ready. Ask whether a referral is required, which visits must happen in person and what the study pays for before making travel plans.

Check all options for your pet →

Free to use. No registration or paid report.